Pages that link to "Q43494872"
Jump to navigation
Jump to search
The following pages link to Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. (Q43494872):
Displaying 50 items.
- Pharmacological treatments for non-alcohol related fatty liver disease (NAFLD): a network meta-analysis (Q24186865) (← links)
- Bariatric surgery for non-alcoholic steatohepatitis in obese patients (Q24240455) (← links)
- Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease (Q24319917) (← links)
- Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link (Q24631619) (← links)
- NAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms? (Q26750955) (← links)
- Hypoxia-inducible factors as molecular targets for liver diseases (Q26752304) (← links)
- A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD (Q26752487) (← links)
- Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome (Q26765455) (← links)
- Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects (Q26775055) (← links)
- Comorbidities and Metabolic Derangement of NAFLD (Q26777147) (← links)
- Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma (Q26781477) (← links)
- The Role of Dendritic Cells in Fibrosis Progression in Nonalcoholic Fatty Liver Disease (Q26784452) (← links)
- Drug Induced Steatohepatitis: An Uncommon Culprit of a Common Disease (Q26798157) (← links)
- Nonalcoholic Fatty liver disease and risk of diabetes and cardiovascular disease: what is important for primary care physicians? (Q26827169) (← links)
- Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity (Q26828547) (← links)
- Lifestyle interventions for the treatment of non-alcoholic fatty liver disease (Q26862945) (← links)
- Epidemiology of fatty liver: an update (Q27000114) (← links)
- Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age? (Q27006992) (← links)
- The Global Nonalcoholic Fatty Liver Disease Epidemic: What a Radiologist Needs to Know (Q27008277) (← links)
- Therapeutic approaches to non-alcoholic fatty liver disease: past achievements and future challenges (Q27023893) (← links)
- Effects of lixisenatide on elevated liver transaminases: systematic review with individual patient data meta-analysis of randomised controlled trials on patients with type 2 diabetes (Q27025423) (← links)
- Toll-like receptors in pathophysiology of liver diseases (Q28070077) (← links)
- Gut microbiota and non-alcoholic fatty liver disease (Q28085158) (← links)
- NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice (Q28254441) (← links)
- Regressive Effect of Myricetin on Hepatic Steatosis in Mice Fed a High-Fat Diet (Q28354293) (← links)
- High serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational study (Q28474831) (← links)
- Sexually dimorphic genome-wide binding of retinoid X receptor alpha (RXRα) determines male-female differences in the expression of hepatic lipid processing genes in mice (Q28535445) (← links)
- Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease (Q28539434) (← links)
- Combination of diabetes risk factors and hepatic steatosis in Chinese: the Cardiometabolic Risk in Chinese (CRC) Study (Q28540317) (← links)
- Liver Patt1 deficiency protects male mice from age-associated but not high-fat diet-induced hepatic steatosis (Q28586093) (← links)
- Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults (Q29614911) (← links)
- NAFLD and liver transplantation: Current burden and expected challenges (Q30248646) (← links)
- Association of maternal diabetes/glycosuria and pre-pregnancy body mass index with offspring indicators of non-alcoholic fatty liver disease. (Q30386847) (← links)
- Prevalence and sonographic changes compatible with fatty liver disease in patients referred for abdominal ultrasound examination in Aracaju, SE. (Q30390099) (← links)
- Prevalence and Factors Associated with Nonalcoholic Fatty Liver Disease in a Nonobese Korean Population (Q30393424) (← links)
- Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis. (Q30402192) (← links)
- The association of nonalcoholic fatty liver disease with central and peripheral blood pressure in adolescence: findings from a cross-sectional study (Q30418630) (← links)
- Value of 3 Tesla diffusion-weighted magnetic resonance imaging for assessing liver fibrosis (Q30420473) (← links)
- Fatty liver, carotid disease and gallstones: a study of age-related associations (Q30433376) (← links)
- Standardized ultrasound hepatic/renal ratio and hepatic attenuation rate to quantify liver fat content: an improvement method (Q30504580) (← links)
- Liver fat volume fraction quantification with fat and water T1 and T 2* estimation and accounting for NMR multiple components in patients with chronic liver disease at 1.5 and 3.0 T. (Q30616960) (← links)
- Noninvasive fatty liver markers predict liver disease mortality in the U.S. population (Q30732041) (← links)
- Quantification of the triglyceride fatty acid composition with 3.0 T MRI. (Q30842915) (← links)
- The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population (Q33262505) (← links)
- Prevalence and factors associated with the presence of non alcoholic fatty liver disease in an apparently healthy adult population in primary care units (Q33305022) (← links)
- Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients (Q33308506) (← links)
- Risk factors associated with non-alcoholic fatty liver disease in subjects from primary care units. A case-control study (Q33373532) (← links)
- The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease (Q33437876) (← links)
- A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease (Q33490839) (← links)
- Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest) (Q33562288) (← links)